E.g., 06/15/2024
E.g., 06/15/2024
Titlesort descending Category Credit Event Date Price
Life Long Learning Prep Course Webcast: Module 1: Oncology, Urinary Diversion and Adrenal (2021) $1,055.00 Specifically designed for anyone unable to get away from the office to attend the Live Course, the Webcast option delivers the same great content. Purchase of the Webcast features simultaneous presentation slides and audio recorded from the Live Course and includes access to online course materials.
Life Long Learning Prep Course Webcast: Module 2: Calculi, Laparoscopy-Robotics and Upper Tract Obstruction (2021) $1,055.00 Specifically designed for anyone unable to get away from the office to attend the Live Course, the Webcast option delivers the same great content. Purchase of the Webcast features simultaneous presentation slides and audio recorded from the Live Course and includes access to online course materials.
Life Long Learning Prep Course Webcast: Module 3: Impotence, Infertility and Andrology (2021) $1,055.00 Specifically designed for anyone unable to get away from the office to attend the Live Course, the Webcast option delivers the same great content. Purchase of the Webcast features simultaneous presentation slides and audio recorded from the Live Course and includes access to online course materials.
Life Long Learning Prep Course Webcast: Module 4: Office Based Urology (2021) $1,055.00 Specifically designed for anyone unable to get away from the office to attend the Live Course, the Webcast option delivers the same great content. Purchase of the Webcast features simultaneous presentation slides and audio recorded from the Live Course and includes access to online course materials.
Management of Non-Muscle Invasive Bladder Cancer: Practical Solutions for Common Problems Webcast (2024)
    • 2.00 AMA PRA Category 1 Credit™
    • 2.00 Non-Physician Participation
$0.00 This course will focus on specific topics discussed in the recent AUA Practice Guidelines for non-muscle invasive bladder cancer (NMIBC) and detail strategies to manage common clinical predicaments involved in the management of these tumors. The course will include short didactic lectures by each of the faculty but will focus predominantly on case presentations highlighting common and often perplexing topics in NMIBC.
New AUA Guideline (2024): Salvage Therapy for Prostate Cancer Webcast (2024)
    • 2.00 AMA PRA Category 1 Credit™
    • 2.00 Non-Physician Participation
$0.00 The course details the 2024 AUA Guidelines for salvage therapy following initial treatment of localized prostate cancer, focusing on integral aspects of salvage treatments, risk stratification and advanced imaging. Participants will gain insights into the timing and appropriate use of salvage radiation therapy with or without androgen deprivation therapy (ADT), the use of risk stratification tools and the application of next-generation imaging in patients with biochemical recurrence.
PARPi: Genetic Testing in Advanced Prostate Cancer - When and Who to Test Webcast (2023)
    • 1.00 AMA PRA Category 1 Credit™
    • 1.00 Non-Physician Participation
$0.00 The American Urological Association (AUA) has developed a series of live virtual and on-demand educational offerings to further address the identified educational gaps and barriers in advanced prostate cancer care. Based on the documented need from the AUA Advanced Prostate Cancer Global Needs Assessments, a three-part educational series to update urologists and advanced practice providers (APPs) on PARP-inhibitor (PARPi) treatment in advanced prostate cancer is being offered.
PARPi: Management of Adverse Events Webcast (2024)
    • 1.00 AMA PRA Category 1 Credit™
    • 1.00 Non-Physician Participation
$0.00 The American Urological Association (AUA) has developed a series of live virtual and on-demand educational offerings to further address the identified educational gaps and barriers in advanced prostate cancer care. Based on the documented need from the AUA Advanced Prostate Cancer Global Needs Assessments, a three-part educational series to update urologists and advanced practice providers (APPs) on PARP-inhibitor (PARPi) treatment in advanced prostate cancer is being offered.
PARPi: Precision Medicine in Advanced Prostate Cancer Webcast (2023)
    • 1.00 AMA PRA Category 1 Credit™
    • 1.00 Non-Physician Participation
$0.00 The American Urological Association (AUA) has developed a series of live virtual and on-demand educational offerings to further address the identified educational gaps and barriers in advanced prostate cancer care. Based on the documented need from the AUA Advanced Prostate Cancer Global Needs Assessments, a three-part educational series to update urologists and advanced practice providers (APPs) on PARP-inhibitor (PARPi) treatment in advanced prostate cancer is being offered.
Practical Implementation of Third-Line Therapies for Refractory Overactive Bladder (OAB) Webcast (2024)
    • 2.00 AMA PRA Category 1 Credit™
    • 2.00 Non-Physician Participation
$0.00 Learners will be presented with case-based and guidelines-based information regarding when to introduce third-line therapies to patients for potentially refractory overactive bladder (OAB), presentation (scripting) techniques to impart important information to patients with user-friendly comprehensible language and analogies to help the patients receive the counseling, pros and cons of each of the third-line therapies, technical tips on optimal delivery of the three third-line therapies and how to select which therapies are the best fit for a given patient.
Practice Management & Coding Program Webcast (2022) $1,095.00 Management, Leadership and Coding for Your Urology Practice! This two session webcast combines the AUA’s ever popular Practice Management Conference and annual Coding Seminar into one comprehensive course offering. The purpose of this webcast is to educate physicians and non-physicians alike on the topics impacting the management of today’s urology practice with an increased emphasis on coding and reimbursement. 
Practice Management Program Webcast (2021) $299.00 Complimentary Webcast for AUA Members and Practice Managers' Network Subscribers! 
Prostate Cancer Diagnosis: AUA Guidelines on use of PSA Biomarkers, MRI and Biopsy Techniques Webcast (2024)
    • 2.00 AMA PRA Category 1 Credit™
    • 2.00 Non-Physician Participation
$0.00 Prostate cancer detection remains one of the most common and most controversial aspects of urological practice. In addition to the complexities around screening and use of PSA, the role of other biomarkers, biopsy techniques such as transperineal biopsy and MRI for targeted biopsy are evolving rapidly. This course is intended for urologists, advanced practice providers and trainees interested in using the most evidence-based methods for optimizing detection of clinically important prostate cancers, while improving patient experience and minimizing complications.
The Changing Face of Advanced Prostate Cancer 2023 Webcast (2024)
    • 2.00 AMA PRA Category 1 Credit™
    • 2.00 Non-Physician Participation
$0.00 This is an ongoing course on advanced prostate cancer at the annual AUA since 2012, and the changes over the last decade have been nothing less than breathtaking! In the early years, it was all about metastatic castrate-resistant prostate cancer (CRPC) with multiple new therapeutic advances starting in 2010 followed by novel oral hormonal therapies and a focus on bone-targeted agents. Later, the course expanded to cover hormone-sensitive (HS) advanced disease due to the new data on chemotherapy and novel ADT extending survival in new M1 patients.
The Evolving Landscape of Advanced Prostate Cancer Treatment: A Guidelines and Case-Based Discussion Webcast (2024)
    • 4.75 AMA PRA Category 1 Credit™
    • 4.75 Non-Physician Participation
$0.00 This comprehensive, interactive course equips urologic professionals with the knowledge and skills needed to effectively manage patients with advanced prostate cancer. Through an in-depth exploration of guidelines, treatment modalities, and emerging therapies, participants will gain a thorough understanding of this complex disease and its evolving landscape.

Pages